Merck KGaA
MKKGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $48,282,099 | $47,847,501 | $55,100,693 | $60,126,948 |
| - Cash | $2,251,000 | $1,166,000 | $1,005,000 | $2,149,000 |
| + Debt | $0 | $0 | $0 | $10,271,000 |
| Enterprise Value | $46,031,099 | $46,681,501 | $54,095,693 | $68,248,948 |
| Revenue | $5,318,000 | $5,255,000 | $5,280,000 | $5,418,000 |
| % Growth | 1.2% | -0.5% | -2.5% | – |
| Gross Profit | $3,213,000 | $3,027,000 | $3,145,000 | $3,099,000 |
| % Margin | 60.4% | 57.6% | 59.6% | 57.2% |
| EBITDA | $1,706,000 | $1,365,000 | $1,507,000 | $1,419,000 |
| % Margin | 32.1% | 26% | 28.5% | 26.2% |
| Net Income | $902,000 | $652,000 | $735,000 | $667,000 |
| % Margin | 17% | 12.4% | 13.9% | 12.3% |
| EPS Diluted | 0.41 | 0.3 | 0.34 | 0.31 |
| % Growth | 36.7% | -11.8% | 9.7% | – |
| Operating Cash Flow | $1,518,000 | $567,000 | $556,000 | $1,231,000 |
| Capital Expenditures | -$461,000 | -$444,000 | -$524,000 | -$509,000 |
| Free Cash Flow | $1,057,000 | $123,000 | $32,000 | $722,000 |